Advertisement

Topics

Speakers Announced for 2018 ISPE Continuous Manufacturing Workshop

14:00 EDT 14 Mar 2018 | PR Web

This event will feature cutting-edge presentations from leaders in the field who have implemented continuous manufacturing strategies and launched successful projects.

BETHESDA, Md. (PRWEB) March 14, 2018

The International Society for Pharmaceutical Engineering (ISPE) announced the speaker line-up for their 2018 Continuous Manufacturing Workshop, taking place in 6–7 June in Arlington, Virginia USA, in conjunction with the 2018 Pharmaceutical Quality Week. Returning for the first time since 2016, this event will feature cutting-edge presentations from leaders in the field who have implemented continuous manufacturing strategies and launched successful projects.

“The goal of the workshop is to provide a snapshot of the current status of continuous manufacturing for small molecules that will benefit everyone from novices to experts in the field,” said Christine Moore, PhD, Program Committee Chair and Global Head and Executive Director, Merck & Co. “Many conference sessions have discussed the theoretical aspects of continuous manufacturing, but this event will feature implementation experience. We are pleased to bring together a dynamic speaker line-up of regulators and users of the technology to share their successes, challenges, and lessons learned.”

This event will feature global industry experts and regulators, including:

  • Lawrence Yu, PhD, Deputy Director, FDA/CDER/OPQ
  • Celia N. Cruz, PhD, Director, Division of Product Quality Research, FDA/CDER/OPQ/OTR/DPQR
  • Douglas Hausner, PhD, Associate Director for Industrial Relations and Business Development, Rutgers University
  • Mark Birse, Group Manager Inspectorate, MHRA
  • W. Darin Moody, Senior Vice President, Global API and Dry Products Manufacturing, Eli Lilly and Company
  • Yoshihiro Matsuda, Deputy Director, Pharma Medical Devices Agency (PMDA)

For the complete speaker line-up for this ISPE event and to register, visit http://www.ISPE.org/Conferences/2018-Continuous-Manufacturing-Workshop.

The Continuous Manufacturing Workshop will be held as part of three key events recognizing the pharmaceutical and biopharmaceutical industry’s efforts to improve product quality and patient health during the 2018 ISPE Pharmaceutical Quality Week. This week will also feature the Quality Manufacturing Conference focusing on the opportunities to ensure continual improvement in pharmaceutical and biopharmaceutical manufacturing and five in-depth pharma training courses: biopharmaceutical manufacturing facilities, GAMP® 5, oral solid dosage (OSD), Quality by Design (QbD), and commissioning and qualification (C&Q).

About ISPE
The International Society for Pharmaceutical Engineering (ISPE) is the world’s largest not-for-profit association serving its members through leading scientific, technical, and regulatory advancement across the entire pharmaceutical lifecycle. The 18,000 members of ISPE are building solutions in the development and manufacture of safe, effective pharmaceutical and biologic medicines, and medical delivery devices in more than 90 countries around the world. Founded in 1980, ISPE has its worldwide headquarters in Bethesda, Maryland USA, and an operations and training center in Tampa, Florida USA. Visit http://www.ISPE.org for more information.

For more information, contact:
Maria Robertson
Senior Director, Marketing Communications
International Society for Pharmaceutical Engineering (ISPE)
Tel: +1-301-364-9207
Email: mrobertson(at)ispe(dot)org
http://www.ISPE.org

For the original version on PRWeb visit: http://www.prweb.com/releases/2018/03/prweb15315045.htm

NEXT ARTICLE

More From BioPortfolio on "Speakers Announced for 2018 ISPE Continuous Manufacturing Workshop"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...